1. Home
  2. HROW vs DAKT Comparison

HROW vs DAKT Comparison

Compare HROW & DAKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HROW

Harrow Inc.

N/A

Current Price

$28.30

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo Daktronics Inc.

DAKT

Daktronics Inc.

N/A

Current Price

$19.53

Market Cap

846.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
HROW
DAKT
Founded
1998
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
846.9M
IPO Year
2008
1996

Fundamental Metrics

Financial Performance
Metric
HROW
DAKT
Price
$28.30
$19.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
2
Target Price
★ $62.63
$33.67
AVG Volume (30 Days)
★ 635.5K
459.9K
Earning Date
11-09-2026
12-09-2026
Dividend Yield
N/A
N/A
EPS Growth
71.43
★ 538.10
EPS
N/A
★ 0.40
Revenue
N/A
★ $608,932,000.00
Revenue This Year
$28.13
$6.68
Revenue Next Year
$56.02
$7.97
P/E Ratio
★ N/A
$49.88
Revenue Growth
N/A
★ 6.89
52 Week Low
$25.76
$16.77
52 Week High
$54.98
$28.27

Technical Indicators

Market Signals
Indicator
HROW
DAKT
Relative Strength Index (RSI) 47.12 52.49
Support Level $27.75 $18.92
Resistance Level $30.28 $20.74
Average True Range (ATR) 1.66 0.74
MACD 0.31 -0.03
Stochastic Oscillator 35.42 33.06

Price Performance

Historical Comparison
HROW
DAKT

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

Share on Social Networks: